Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 12, 2020

Total Value: $313M (100.0% shares, 0.0% debt)

Holdings (15)

BBIO BridgeBio Pharma Inc (BBIO) 47.8%

Value $150M Shares 3,989,412 Est. Cost $27.40 Unrealized +14.8%

— Eidos Therapeutics, Inc. (EIDIX) 18.1%

Value $56.78M Shares 1,123,630 Est. Cost $13.76 Unrealized —

HRMY HARMONY BIOSCIENCES HLDGS IN (HRMY) 9.1%

Value $28.57M Shares 842,815 Est. Cost $36.46 Unrealized 0.0%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 4.8%

Value $15.13M Shares 1,025,000 Est. Cost $10.24 Unrealized +48.9%

— AVROBIO, Inc. (AVRO) 4.2%

Value $13.15M Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 3.8%

Value $11.99M Shares 1,691,151 Est. Cost $8.00 Unrealized —

— POSEIDA THERAPEUTICS INC (PSTX) 3.0%

Value $9.254M Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Verona Pharma plc (VRNA) 2.7%

Value $8.315M Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Atreca Inc (BCEL) 1.7%

Value $5.416M Shares 387,653 Est. Cost $18.84 Unrealized —

— Zosano Pharma Corporation (ZSAN) 1.4%

Value $4.404M Shares 2,718,226 Est. Cost $2.15 Unrealized —

— ObsEva SA (OBSV) 1.1%

Value $3.438M Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 1.0%

Value $3M Shares 2,000,000 Est. Cost $5.55 Unrealized —

ACRS Aclaris Therapeutics Inc (ACRS) 0.5%

Value $1.631M Shares 634,455 Est. Cost $10.31 Unrealized -78.3%

— Sunesis Pharmaceuticals, Inc. (SNSS) 0.4%

Value $1.263M Shares 1,010,000 Est. Cost $0.89 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.3%

Value $1.018M Shares 1,910,287 Est. Cost $1.49 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc (BBIO)	3,989,412	$150M	47.8%	$27.40	+14.8%	COM	10806X102
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$56.78M	18.1%	$13.76	—	COM	28249H104
HRMY	HARMONY BIOSCIENCES HLDGS IN (HRMY)	842,815	$28.57M	9.1%	$36.46	0.0%	COM	413197104
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$15.13M	4.8%	$10.24	+48.9%	COM	87164F105
—	AVROBIO, Inc. (AVRO)	1,009,779	$13.15M	4.2%	$16.72	—	COM	05455M100
—	Aeglea Biotherapeutics Inc (AGLE)	1,691,151	$11.99M	3.8%	$8.00	—	COM	00773J103
—	POSEIDA THERAPEUTICS INC (PSTX)	1,043,267	$9.254M	3.0%	$8.87	—	COM	73730P108
—	Verona Pharma plc (VRNA)	1,332,485	$8.315M	2.7%	$7.38	—	COM	925050106
—	Atreca Inc (BCEL)	387,653	$5.416M	1.7%	$18.84	—	CL A COM	04965G109
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$4.404M	1.4%	$2.15	—	COM	98979H202
—	ObsEva SA (OBSV)	1,386,338	$3.438M	1.1%	$12.66	—	COM	H5861P103
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$3M	1.0%	$5.55	—	COM	57055L107
ACRS	Aclaris Therapeutics Inc (ACRS)	634,455	$1.631M	0.5%	$10.31	-78.3%	COM	00461U105
—	Sunesis Pharmaceuticals, Inc. (SNSS)	1,010,000	$1.263M	0.4%	$0.89	—	COM	867328700
—	Nabriva Therapeutics plc (NBRV)	1,910,287	$1.018M	0.3%	$1.49	—	SHS	G63637105